The gene coding for PGC-1α modifies age at onset in Huntington's Disease

Patrick Weydt, Selma M. Soyal, Cinzia Gellera, Stefano Didonato, Claus Weidinger, Hannes Oberkofler, G. Bernhard Landwehrmeyer, Wolfgang Patsch

Research output: Contribution to journalArticle

Abstract

Huntington's disease (HD) is one of the most common autosomal dominant inherited, neurodegenerative disorders. It is characterized by progressive motor, emotional and cognitive dysfunction. In addition metabolic abnormalities such as wasting and altered energy expenditure are increasingly recognized as clinical hallmarks of the disease. HD is caused by an unstable CAG repeat expansion in the HD gene (HTT), localized on chromosome 4p16.3. The number of CAG repeats in the HD gene is the main predictor of disease-onset, but the remaining variation is strongly heritable. Transcriptional dysregulation, mitochondrial dysfunction and enhanced oxidative stress have been implicated in the pathogenesis. Recent studies suggest that PGC-1α, a transcriptional master regulator of mitochondrial biogenesis and metabolism, is defective in HD. A genome wide search for modifier genes of HD age-of-onset had suggested linkage at chromosomal region 4p16-4p15, near the locus of PPARGC1A, the gene coding for PGC-1α. We now present data of 2-loci PPARGC1A block 2 haplotypes, showing an effect upon age-at-onset in 447 unrelated HD patients after statistical consideration of CAG repeat lengths in both HTT alleles. Block 1 haplotypes were not associated with the age-at-onset. Homozygosity for the 'protective' block 2 haplotype was associated with a significant delay in disease onset. To our knowledge this is the first study to show clinically relevant effects of the PGC-1α system on the course of Huntington's disease in humans.

Original languageEnglish
Article number3
JournalMolecular Neurodegeneration
Volume4
Issue number1
DOIs
Publication statusPublished - 2009

Fingerprint

Huntington Disease
Age of Onset
Genes
Haplotypes
Modifier Genes
Organelle Biogenesis
Neurodegenerative Diseases
Energy Metabolism
Oxidative Stress
Chromosomes
Alleles
Genome

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Clinical Neurology
  • Molecular Biology

Cite this

Weydt, P., Soyal, S. M., Gellera, C., Didonato, S., Weidinger, C., Oberkofler, H., ... Patsch, W. (2009). The gene coding for PGC-1α modifies age at onset in Huntington's Disease. Molecular Neurodegeneration, 4(1), [3]. https://doi.org/10.1186/1750-1326-4-3

The gene coding for PGC-1α modifies age at onset in Huntington's Disease. / Weydt, Patrick; Soyal, Selma M.; Gellera, Cinzia; Didonato, Stefano; Weidinger, Claus; Oberkofler, Hannes; Landwehrmeyer, G. Bernhard; Patsch, Wolfgang.

In: Molecular Neurodegeneration, Vol. 4, No. 1, 3, 2009.

Research output: Contribution to journalArticle

Weydt, P, Soyal, SM, Gellera, C, Didonato, S, Weidinger, C, Oberkofler, H, Landwehrmeyer, GB & Patsch, W 2009, 'The gene coding for PGC-1α modifies age at onset in Huntington's Disease', Molecular Neurodegeneration, vol. 4, no. 1, 3. https://doi.org/10.1186/1750-1326-4-3
Weydt, Patrick ; Soyal, Selma M. ; Gellera, Cinzia ; Didonato, Stefano ; Weidinger, Claus ; Oberkofler, Hannes ; Landwehrmeyer, G. Bernhard ; Patsch, Wolfgang. / The gene coding for PGC-1α modifies age at onset in Huntington's Disease. In: Molecular Neurodegeneration. 2009 ; Vol. 4, No. 1.
@article{167987eb3e47467a8551e8bb6e12ab6f,
title = "The gene coding for PGC-1α modifies age at onset in Huntington's Disease",
abstract = "Huntington's disease (HD) is one of the most common autosomal dominant inherited, neurodegenerative disorders. It is characterized by progressive motor, emotional and cognitive dysfunction. In addition metabolic abnormalities such as wasting and altered energy expenditure are increasingly recognized as clinical hallmarks of the disease. HD is caused by an unstable CAG repeat expansion in the HD gene (HTT), localized on chromosome 4p16.3. The number of CAG repeats in the HD gene is the main predictor of disease-onset, but the remaining variation is strongly heritable. Transcriptional dysregulation, mitochondrial dysfunction and enhanced oxidative stress have been implicated in the pathogenesis. Recent studies suggest that PGC-1α, a transcriptional master regulator of mitochondrial biogenesis and metabolism, is defective in HD. A genome wide search for modifier genes of HD age-of-onset had suggested linkage at chromosomal region 4p16-4p15, near the locus of PPARGC1A, the gene coding for PGC-1α. We now present data of 2-loci PPARGC1A block 2 haplotypes, showing an effect upon age-at-onset in 447 unrelated HD patients after statistical consideration of CAG repeat lengths in both HTT alleles. Block 1 haplotypes were not associated with the age-at-onset. Homozygosity for the 'protective' block 2 haplotype was associated with a significant delay in disease onset. To our knowledge this is the first study to show clinically relevant effects of the PGC-1α system on the course of Huntington's disease in humans.",
author = "Patrick Weydt and Soyal, {Selma M.} and Cinzia Gellera and Stefano Didonato and Claus Weidinger and Hannes Oberkofler and Landwehrmeyer, {G. Bernhard} and Wolfgang Patsch",
year = "2009",
doi = "10.1186/1750-1326-4-3",
language = "English",
volume = "4",
journal = "Molecular Neurodegeneration",
issn = "1750-1326",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - The gene coding for PGC-1α modifies age at onset in Huntington's Disease

AU - Weydt, Patrick

AU - Soyal, Selma M.

AU - Gellera, Cinzia

AU - Didonato, Stefano

AU - Weidinger, Claus

AU - Oberkofler, Hannes

AU - Landwehrmeyer, G. Bernhard

AU - Patsch, Wolfgang

PY - 2009

Y1 - 2009

N2 - Huntington's disease (HD) is one of the most common autosomal dominant inherited, neurodegenerative disorders. It is characterized by progressive motor, emotional and cognitive dysfunction. In addition metabolic abnormalities such as wasting and altered energy expenditure are increasingly recognized as clinical hallmarks of the disease. HD is caused by an unstable CAG repeat expansion in the HD gene (HTT), localized on chromosome 4p16.3. The number of CAG repeats in the HD gene is the main predictor of disease-onset, but the remaining variation is strongly heritable. Transcriptional dysregulation, mitochondrial dysfunction and enhanced oxidative stress have been implicated in the pathogenesis. Recent studies suggest that PGC-1α, a transcriptional master regulator of mitochondrial biogenesis and metabolism, is defective in HD. A genome wide search for modifier genes of HD age-of-onset had suggested linkage at chromosomal region 4p16-4p15, near the locus of PPARGC1A, the gene coding for PGC-1α. We now present data of 2-loci PPARGC1A block 2 haplotypes, showing an effect upon age-at-onset in 447 unrelated HD patients after statistical consideration of CAG repeat lengths in both HTT alleles. Block 1 haplotypes were not associated with the age-at-onset. Homozygosity for the 'protective' block 2 haplotype was associated with a significant delay in disease onset. To our knowledge this is the first study to show clinically relevant effects of the PGC-1α system on the course of Huntington's disease in humans.

AB - Huntington's disease (HD) is one of the most common autosomal dominant inherited, neurodegenerative disorders. It is characterized by progressive motor, emotional and cognitive dysfunction. In addition metabolic abnormalities such as wasting and altered energy expenditure are increasingly recognized as clinical hallmarks of the disease. HD is caused by an unstable CAG repeat expansion in the HD gene (HTT), localized on chromosome 4p16.3. The number of CAG repeats in the HD gene is the main predictor of disease-onset, but the remaining variation is strongly heritable. Transcriptional dysregulation, mitochondrial dysfunction and enhanced oxidative stress have been implicated in the pathogenesis. Recent studies suggest that PGC-1α, a transcriptional master regulator of mitochondrial biogenesis and metabolism, is defective in HD. A genome wide search for modifier genes of HD age-of-onset had suggested linkage at chromosomal region 4p16-4p15, near the locus of PPARGC1A, the gene coding for PGC-1α. We now present data of 2-loci PPARGC1A block 2 haplotypes, showing an effect upon age-at-onset in 447 unrelated HD patients after statistical consideration of CAG repeat lengths in both HTT alleles. Block 1 haplotypes were not associated with the age-at-onset. Homozygosity for the 'protective' block 2 haplotype was associated with a significant delay in disease onset. To our knowledge this is the first study to show clinically relevant effects of the PGC-1α system on the course of Huntington's disease in humans.

UR - http://www.scopus.com/inward/record.url?scp=58649094617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58649094617&partnerID=8YFLogxK

U2 - 10.1186/1750-1326-4-3

DO - 10.1186/1750-1326-4-3

M3 - Article

C2 - 19133136

AN - SCOPUS:58649094617

VL - 4

JO - Molecular Neurodegeneration

JF - Molecular Neurodegeneration

SN - 1750-1326

IS - 1

M1 - 3

ER -